Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
The American Journal of Psychiatry|May 1, 1984
Psychiatric implications of basic and clinical studies with corticotropin-releasing factorP W Gold, G Chrousos, C Kellner, et al.The Journal of Clinical Psychiatry|June 1, 1993
Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatientsL K Laird, R B Lydiard, W A Morton, et al.Blood Cancer Journal|June 14, 2014
The novel immunotoxin HM1.24-ETA' induces apoptosis in multiple myeloma cellsM Staudinger, P Glorius, R Burger, et al.The British Journal of Dermatology|February 28, 2016
A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lampU Reinhold, T Dirschka, R Ostendorf, et al.The British Journal of Dermatology|June 4, 2010
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III studyR-M Szeimies, P Radny, M Sebastian, et al.The British Journal of Dermatology|February 19, 2009
Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studiesA Hauschild, E Stockfleth, G Popp, et al.The British Journal of Dermatology|October 7, 2009
Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months dataR-M Szeimies, E Stockfleth, G Popp, et al.Leukemia|May 15, 2007
A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cellsM Schwemmlein, J Stieglmaier, C Kellner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Interlaboratory evaluation of a new reverse transcriptase polymerase chain reaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: a multicenter study of the Dermatologic Cooperative Oncology GroupU Reinhold, C Berkin, A K Bosserhoff, et al.The British Journal of Dermatology|September 2, 2018
Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo-controlled, double-blind clinical trialE Stockfleth, G F L Hofbauer, U Reinhold, et al.Pageof 13